AbbVie Inc (ABBV)
193.98
-0.61
(-0.31%)
USD |
NYSE |
Sep 12, 16:00
194.37
+0.39
(+0.20%)
After-Hours: 20:00
AbbVie Revenue (Quarterly): 14.46B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 14.46B |
March 31, 2024 | 12.31B |
December 31, 2023 | 14.30B |
September 30, 2023 | 13.93B |
June 30, 2023 | 13.86B |
March 31, 2023 | 12.22B |
December 31, 2022 | 15.12B |
September 30, 2022 | 14.81B |
June 30, 2022 | 14.58B |
March 31, 2022 | 13.54B |
December 31, 2021 | 14.89B |
September 30, 2021 | 14.34B |
June 30, 2021 | 13.96B |
March 31, 2021 | 13.01B |
December 31, 2020 | 13.86B |
September 30, 2020 | 12.90B |
June 30, 2020 | 10.42B |
March 31, 2020 | 8.619B |
December 31, 2019 | 8.704B |
September 30, 2019 | 8.479B |
June 30, 2019 | 8.255B |
March 31, 2019 | 7.828B |
December 31, 2018 | 8.305B |
September 30, 2018 | 8.236B |
June 30, 2018 | 8.278B |
Date | Value |
---|---|
March 31, 2018 | 7.934B |
December 31, 2017 | 7.739B |
September 30, 2017 | 6.995B |
June 30, 2017 | 6.944B |
March 31, 2017 | 6.538B |
December 31, 2016 | 6.796B |
September 30, 2016 | 6.432B |
June 30, 2016 | 6.452B |
March 31, 2016 | 5.958B |
December 31, 2015 | 6.40B |
September 30, 2015 | 5.944B |
June 30, 2015 | 5.475B |
March 31, 2015 | 5.04B |
December 31, 2014 | 5.452B |
September 30, 2014 | 5.019B |
June 30, 2014 | 4.926B |
March 31, 2014 | 4.563B |
December 31, 2013 | 5.111B |
September 30, 2013 | 4.658B |
June 30, 2013 | 4.692B |
March 31, 2013 | 4.329B |
December 31, 2012 | 5.206B |
September 30, 2012 | 4.508B |
June 30, 2012 | 4.493B |
March 31, 2012 | 4.173B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.479B
Minimum
Sep 2019
15.12B
Maximum
Dec 2022
12.92B
Average
13.86B
Median
Revenue (Quarterly) Benchmarks
Amgen Inc | 8.388B |
Johnson & Johnson | 22.45B |
Eli Lilly and Co | 11.30B |
Merck & Co Inc | 16.11B |
Pfizer Inc | 13.28B |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 1.37B |
Total Expenses (Quarterly) | 9.527B |
EPS Diluted (Quarterly) | 0.77 |
Enterprise Value | 401.23B |
Gross Profit Margin (Quarterly) | 70.94% |
Profit Margin (Quarterly) | 9.47% |
Earnings Yield | 1.55% |
Operating Earnings Yield | 3.99% |
Normalized Earnings Yield | 1.849 |